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Abstract
Osteointegration is one of the most studied issues and is considered as one of the most 
evaluated cases in implantology. It is important for implantologists to have an in-depth 
understanding of what exist in the bone-implant interface. It is a treatment plan that is 
compatible with standards and provides a better clinical forecast. The present study is a 
comprehensive review from all that have been conducted regarding various aspects of 
osteointegration.
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Introduction
Collins (1954), Southam and Selwyn (1970) refuted the claim 
that bone-implant connection does not contain any fi brous 
layer formation and within several decades of development, 
the layer has existed around the implant and its integration has 
decreased with the bone.[1,2] Professor Brånemark et al. during 
1950s-1960s, while working on microcirculation of bone and 
lesion treatment via microscope, discovered the osteointegration 
process accidentally and brought new lights in implantology 
through better medical choices for patients that increased their 
performance quality and general health. What seemed signifi cant 
in this unexpected fi nding was bone adhesion to titanium with no 
fi brous layer formation, which was inseparable without fraction.[3]
It was Professor Brånemark who used the term 
osteointegration for the fi rst time and since then; the term is used 
to explain the process of bone-titanium connection. Although 
in the past, introduced other terms such as “osteointegration” 
and “osteointegration,” it also recommends the term “osseous 
integration.”[4] In this article, however, we used the term 
“osteointegration.”
Originally, osteointegration was defi ned by Brånemark in 
1985 as a structural and functional connection between the 
desired living bone and the surface of an implant that carries 
graft. In 1981, Albrektsson interpreted this term as a direction in 
the light microscopic level that establishes a connection between 
the living bone and the implant.[5] And in 1986, Steinemann 
described it as a bone connection with resistance to shear and 
tensile strength.[6] In 1990, Brånemark proposed a modifi ed 
defi nition - “A feasibly stable structural and functional symbiosis 
in a symbolic method among distinguished biological tissues 
with remodeling and strictly controlled synthetic compositions 
and it is obvious that the last special clinical function is provided 
before the recoiling mechanism begins.”
The Bone
Osteointegration is a developing process that indicates the 
formation procedure, role, and restoration adoption that, due 
to osteoplastic and bone osteoplastic activity, is known as a 
coupling agent as well.[7-10]
Osteoblasts have mesenchymal origins that are under the 
infl uence of topical growth factors such as fi broblast growth 
factors (FGFs), bone morphogenetic proteins (BMPs), and 
Wnt proteins, which require transcription from Runx2 and 
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Astrix transcription factors.[11] Moreover, osteoblasts direct the 
osteoclasts activity by the secretion of osteoprotegerin, which 
is a RANK trap that inhibits the reabsorption of osteoblast 
bone.[12,13]
Osteoclasts are bone absorbing cells and work in connection 
with osteoblasts, while osteocytes are new cells that are being 
trapped inside the new bone matrix. They make a connection 
with other bone cells through protruding the cell membrane in 
tunnels, which is called canaliculi. The role of these network cells 
is relatively unknown and however, they play a signifi cant part in 
bone absorption[14] and the sense of mechanical loading.[15]
Although epithelial bone cells mostly cover the static bone 
surface, yet their function is somehow unknown, and there are 
doubts regarding their region.[16]
Bone-implant interface events
As soon as the implant is placed in the prepared space, within 
a limited time as long as nanoseconds, the layer of water 
molecules form in its surrounding, which is considerably under 
the infl uence of implant surface.[17] This layer facilitates protein 
and other molecule absorptions within the implant surface.[18,19] 
In the second stage, within 30 s to several hours after the implant, 
the surface will be coated with a layer comprised of intercellular 
matrix proteins. Its structure, inclination, and composition 
depend on the surface type. These proteins initially come 
from blood and interstitial fl uid in wound location and then 
derive from cell activity in the area around the prosthesis.[20] 
In the third stage, cells interaction with the implant surface 
occurs via a protein layer, which is initiated by cell adhesion, 
migration, and diﬀ erentiation that lasts for several hours or 
days.[21] This phase is fi nely adjusted with extracellular matrix 
(ECM) proteins, cell surface binding and cytoskeleton proteins, 
chemical characteristics, binding topography, and chemical ion 
release.[22]
ECM carries information that could be decoded by cells 
and cohesive structures, as well as cell shape, organizing 
cytoskeleton, mobility and polarity of the cell, gene expression, 
proliferation, and survival. The process includes collagen Type I, 
proteoglycans, and nano collagen proteins.[23-25]
In fact, ECM is a data transmitting method included 
in a number of proteins, such as collagen I, fi bronectin, 
thrombospondin, osteonectin, osteopontin, osteoadrin, and 
bone sialoprotein (BSP), as well as specifi c plasma proteins 
like α2HS glycoprotein,[20] which mostly acts like cell adhesion 
interfaces and some as messengers with cell to cell/cell to protein 
interaction.[26] Moreover, protein serums like albumin are 
absent which indicates selective agglomeration/sedimentation 
of molecules in the interface. Molecules that contain Arg-
Gly-ASP or RGD sequence contribute to cell adhesion and 
mineral binding. This RGD sequence is present in a number of 
ECM proteins such as fi brin, collagen, fi bronectin, vitronectin, 
osteopontin, and BSP.[27]
Cellular connection is a complicated process and forms by 
integrin, focal adhesion, and fi lopodia. Integrins are membrane 
transporters of cell surface receptors that mediate between the 
physical binding of cell to the outside of matrix to broadcast 
messages from outside in and vice versa.[28,29] They have α 
and β subunits with cells, expressing various combinations of 
integrins.[30] Canonical cohesion of integrin is based on cell 
molecule compositions participating in a messaging-based 
cohesion[31,32] and binding ECM to the actomyosin of cell 
cytoskeleton.[33] These structures are moving and based on the 
cell, could be bonded, detached, dispersed, and recovered.[33,34] 
Filopodia is an actin-rich cell appendage that, along the cell, 
causes cohesion on rough surfaces.[35] Surface structures scan 
the fi lopodia layer and stabilize the cell in line with the receiving 
signals from cavities with micro and sub-micrometer structures, 
acting as an appropriate setting during the route fi nding phase. 
A desirable support will shape with certain points along the 
fi lopodia as well as the tip of these points. These tips that become 
wide and branch outward will convert the sticky structures 
that are known as footpads. Cell expansion interfaces with 
cell membrane appendages in footpads or with the bulge of a 
cytoplasmic disk, which means that it is similar to a lamella or 
lamellipodium between sticky fi lopodia.[36-38] On the other hand, 
cells stick to the fl at surface through canonical cohesion. When 
this surface is scanned, fi lopodia receives negative signals, which 
go back to the cell body. The process leads to developed stress 
fi bers that impose the stress along the cell body and by increasing 
the cells’ connection to the surrounding, they will become 
smoother.[35]
During the fi rst day of implant placement, it is the water 
molecules and platelet absorption that secretes the growth 
factors. Moreover, messaging and provoking osteoblasts to stick 
in cell level becomes possible through the aid of fi bronectin 
that is interfacing with canonical cohesion.[39] Pluripotent 
mesenchymal cells are the fi rst to migrate along the implant 
level. They do not deliver osteoblasts.[40] The ability of these 
cells to distinguish active osteoblasts depends on topical oxygen 
tension, food availability, and local regulatory growth factors; all 
of which depend on the angiogenesis of implant position and 
the physiology of transplant.[41] Migration of these cells is also 
contingent to the decrease of oxygen concentration gradient 
toward the center of wound that is due to local ischemia and 
necrosis. Local ischemia and necrosis are the result of circulation 
stop and lack of oxygen for osteoblasts due to the breakage of 
capillaries. Although neutrophils are the most abundant cells 
to reach their peaks (maximum) within 24-48 h, yet later on 
macrophages become dominant. Both of these cells are involved 
in forming clots and tissue necrosis.
During the third day, related osteoblast transcription factors 
of Runx2 and Op are activated by the cells around the implant. 
By the 4th day, the created necrotic bone within the surgery is 
reabsorbed and a certain interface zone is formed. In the 5th day, 
some evidences are observable from the new bone formation and 
the presence of alkaline phosphatase activity, which indicates the 
beginning of mineralization and matrix remodeling.[42] By the 
end of fi rst week, the cohesion of bone matrix on the surface 
of implant could be recognized easily, ECM becomes engaged 
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in the surface and bone cavities reach to 35.8 ± 7.2% implant 
connection ratio. Up to the 16th day, the implant surface becomes 
fully and abundantly coated with a mixture of mineralized tissues, 
osteoid, and dense matrix.[43]
On the 28th day, which is the end of 4th week, the main bone 
establishes a complete binding along the implant surface and 
also in the neck, collagen fi bers, and osteoblasts create a volume 
of tissue layer adjacent to the implant; while collagen fi bers 
incline toward themselves becoming parallel to the implant 
surface and cells, ECM proteins, and mineralized bone tissue 
appear in direct relationship with the implant and bone to 
reach the size of 46.3 ± 17.7% in implant ratio.[44] According 
to Davies;[45] Puleo and Nanci,[20] ossifi cation occurs in two 
directions, from implant surface toward the bone and from 
the bone toward the implant surface, which is known as bone 
regeneration and distance bone regeneration [Figures 1 and 2]. 
In the process of bone regeneration within the contact area, the 
bone gets shaped 30% faster. In this mode, prior to the formation 
of bone matrix, the implant surface clone with bone cells, and the 
identical mesenchyme, which was created during the remodeling 
process is recognized as new bone formation. In distance bone 
regeneration, the new bone is formed on the surface of implant 
while the implant is covered by the surrounding bone. It is 
expected that this procedure occurs in cortical bone healing.[45] 
The initial bones are formed woven, which have osteoid in their 
matrix. At the end of 12th week, the new bone that is formed at 
the implant surface will be uniformed with a body connection of 
mature lamellar bone with titanium surface.[43]
Conclusion
Osteointegration is a fairly complicated process and the aspects 
of micro and micro molecule bone-implant interface are the 
matters of controversy. However, through the use of conducted 
tests and studies of many authors, we can claim that the 
treatment patterns in cortical and trabecular bones are diﬀ erent. 
Cortical healing depends on the remodeling of haversian, while 
trabecular healing is based on osteoconduction phenomenon 
(bone growth on the surface) and the formation of new bone.
Bone formation in the position of bone lesion takes 
place due to coupling mechanism and according to frost, the 
mechanism of formation and reabsorption should be existing. 
The biomechanical milieu in position failure immediately aﬀ ects 
cartilage and bone development.
Once the position of implant placement is prepared, a lesion 
is made and the phase of bone-implant healing is performed by 
a method similar to healing in the case of a broken bone, since 
both operations start with penetration in an intact skeletal 
position, an immune response, a new angiogenesis, and use 
skeletal progenitor cells. Nevertheless, some skeletal progenitor 
cells will diﬀ erentiate into chondrocytes in cases of bone failure, 
while the others will change into osteoblasts that are followed by 
ossifi cation inside the cartilage. Around an implant, all skeletal 
progenitor cells that change into osteoblast are followed with 
intra-membranous ossifi cation. The other contradiction in 
implant healing is that the osteointegration process is extremely 
under the infl uence of implant surface, chemical composition, 
and implant biomechanics.[46,47]
Hence, as soon as the implant is located, platelet density 
takes place.[45] These platelets secrete the growth factors, such 
as platelet-derived growth factor-BB, insulin-like growth factor 
(IGF, IGF-2), FGFs (a-FGF, b-FGF), transitional growth 
factor beta, BMPs, vasoactive factors of serotonin and histamine 
[Figure 3]. These factors are more diﬀ erentiated, proliferated, 
and bound to osteoblasts with titanium level [Figure 4] and form 
a new matrix [Figure 5]. The development is managed by the 
transcription factor protein core binding-factor-alpha.[48]
There are ample evidences to prove the direct relationship 
between osteointegration and superfi cial topography. It is 
verifi ed that the rough surface made osteointegration binding 
better, resulting in fi lopodia, as well as a four layer increase in 
cbcfa1.[48] We also surmise that, an increase in the surface is 
not a defi nitive factor for regulating cell growth in the bone-
implant interface. Consequently, implant surface topography 
Figure 1: Distance osteogenesis
Figure 2: Contact osteogenesis
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satellite-like rough surface cells.[35] Therefore, the bone matrix 
in the bone-implant interface is formed during the bone growth 
on the surface [osteoconduction], simulating ossifi cation 
(osteoinduction), bone regeneration (osteogenesis), and bone 
progress (osteopromotion).[26]
Bone growth in the surface refers to the orientation of 
formed bone activity to the position or specifi c surface, like 
hydroxyapatite coating, which is retained as a framework for 
making cell connection and growth. Stimulation of ossifi cation 
includes applying mesenchymal stem cells that will be converted 
to osteoblasts. Implant surfaces are not stimulating. Bone 
regeneration is related to the stimulation of proliferation of 
bone progenitor cells and the stimulation of the biosynthetic 
activity of osteoblasts. As the fourth modifi cation, although bone 
progress is relatively a new term, is related to the formation of 
bone in topical bone positions through using techniques that are 
related to membrane barriers, and is only utilized in promoting 
clinical cells.
There are many unanswered questions; however, there is 
no fi eld of study in implantology that thoroughly investigates 
osteointegration. The current results and future research 
projects represent better understanding and a fi ner transparent 
image of what is happening in the bone-implant interface, 
which subsequently provides the required information for 
implantologists. These fi ndings, after understanding the 
physiological and biological needs of bone, can supply the 
patients with the best possible medical treatments.
References
1. Albrektsson T, Albrektsson B. Osseointegration of bone 
implants. A  review of an alternative mode of fi xation. Acta 
Orthop Scand 1987;58:567-77.
2. Brånemark R, Brånemark PI, Rydevik B, Myers RR. 
Osseointegration in skeletal reconstruction and rehabilitation: 
A review. J Rehabil Res Dev 2001;38:175-81.
3. Brånemark PI. Osseointegration and its experimental 
background. J Prosthet Dent 1983;50:399-410.
4. VanBlarcom CW. Th e Glossary of Prosthodontic Terms. St. 
Louis: Mosby; 1999.
5. Albrektsson T, Brånemark PI, Hansson HA, Lindström J. 
Osseointegrated titanium implants. Requirements for ensuring 
a long-lasting, direct bone-to-implant anchorage in man. Acta 
Orthop Scand 1981;52:155-70.
6. Nayab S, Shinawi L, Hobkirk J, Tate T, Olsen I, Jones F. Adhesion 
of bone cells to ion-implanted titanium. J Mater Sci Mater Med 
2003;14:991-7.
7. Muhonen V, Heikkinen R, Danilov A, Jämsä T, Tuukkanen J. 
Th e eff ect of oxide thickness on osteoblast attachment and 
survival on NiTi alloy. J J Mater Sci Mater Med 2007;18:959-67.
8. Rodan GA, Martin TJ. Role of osteoblasts in hormonal control of 
bone resorption – A hypothesis. Calcif Tissue Int 1981;33:349-51.
9. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, 
et al. Osteoprotegerin ligand is a cytokine that regulates 
osteoclast diff erentiation and activation. Cell 1998;93:165-76.
10. Cooper LF, Masuda T, Yliheikkilä PK, Felton DA. 
Generalizations regarding the process and phenomenon of 
Figure 3: Secretion of growth factors from platelets
Figure 4: Diff erentiation and proliferation of growth factors and 
attachment of osteoblasts with titanium surface
Figure 5: Formation of new bone matrix
plays a signifi cant role and changes the cell structure, as if the 
smooth surface osteoblasts inclined parallel and are on the 
Hosseini, et al. Osseointegration of bone implants
5
osseointegration. Part II. In vitro studies. Int J Oral Maxillofac 
Implants 1998;13:163-74.
11. Komori T. Regulation of bone development and maintenance by 
Runx2. Front Biosci 2007;13:898-903.
12. Buckwalter J, Glimcher M, Cooper R, Recker R. Bone biology. 
J Bone Joint Surg Am 1995;77:1256-75.
13. Roodman GD. Advances in bone biology: Th e osteoclast. 
Endocr Rev 1996;17:308-32.
14. Shimizu H, Sakamoto M, Sakamoto S. Bone resorption by 
isolated osteoclasts in living versus devitalized bone: Diff erences 
in mode and extent and the eff ects of human recombinant tissue 
inhibitor of metalloproteinases. J Bone Miner Res 1990;5:411-8.
15. Tatsumi S, Ishii K, Amizuka N, Li M, Kobayashi T, Kohno K, 
et al. Targeted ablation of osteocytes induces osteoporosis with 
defective mechanotransduction. Cell Metab 2007;5:464-75.
16. Weinmann JP, Sicher H. Bone and Bones: Fundamentals of 
Bone Biology. St. Louis: Mosby; 1955.
17. Singhatanadgit W. Biological responses to new advanced 
surgace modifi cations of endosseous medical implants. Bone 
Tissue Regen Insights 2009;2:1-11.
18. Shard AG, Tomlins PE. Biocompatibility and the effi  cacy of 
medical implants. Regen Med 2006;1:789-800.
19. Th evenot P, Hu W, Tang L. Surface chemistry infl uences implant 
biocompatibility. Curr Top Med Chem 2008;8:270-80.
20. Puleo DA, Nanci A. Understanding and controlling the bone-
implant interface. Biomaterials 1999;20:2311-21.
21. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of 
biomaterial-cell interactions by adsorbed proteins: A  review. 
Tissue Eng 2005;11:1-18.
22. Ratner BD, Bryant SJ. Biomaterials: Where we have been and 
where we are going. Annu Rev Biomed Eng 2004;6:41-75.
23. Damsky CH, Werb Z. Signal transduction by integrin receptors 
for extracellular matrix: Cooperative processing of extracellular 
information. Curr Opin Cell Biol 1992;4:772-81.
24. Globus RK, Doty SB, Lull JC, Holmuhamedov E, Humphries MJ, 
Damsky CH. Fibronectin is a survival factor for diff erentiated 
osteoblasts. J Cell Sci 1998;111:1385-93.
25. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, 
et al. Fibronectin regulates calvarial osteoblast diff erentiation. 
J Cell Sci 1996;109 (Pt 6):1369-80.
26. Cooper LF. Biologic determinants of bone formation for 
osseointegration: Clues for future clinical improvements. 
J Prosthet Dent 1998;80:439-49.
27. Schwartz Z, Lohmann CH, Oefi nger J, Bonewald LF, 
Dean DD, Boyan BD. Implant surface characteristics modulate 
diff erentiation behavior of cells in the osteoblastic lineage. Adv 
Dent Res 1999;13:38-48.
28. Hynes RO. Integrins: A family of cell surface receptors. Cell 
1987;48:549-54.
29. Takagi J, Petre BM, Walz T, Springer TA. Global conformational 
rearrangements in integrin extracellular domains in outside-in 
and inside-out signaling. Cell 2002;110:599-11.
30. Clover J, Dodds RA, Gowen M. Integrin subunit expression 
by human osteoblasts and osteoclasts in situ and in culture. 
J Cell Sci 1992;103 (Pt 1):267-71.
31. Abercrombie M, Heaysman JE, Pegrum SM. Th e locomotion 
of fi broblasts in culture. IV. Electron microscopy of the leading 
lamella. Exp Cell Res 1971;67:359-67.
32. Avnur Z, Geiger B. Th e removal of extracellular fi bronectin 
from areas of cell-substrate contact. Cell 1981;25:121-32.
33. Sastry SK, Burridge K. Focal adhesions: A nexus for 
intracellular signaling and cytoskeletal dynamics. Exp Cell Res 
2000;261:25-36.
34. Smilenov LB, Mikhailov A, Pelham RJ, Marcantonio EE, 
Gundersen GG. Focal adhesion motility revealed in stationary 
fi broblasts. Science 1999;286:1172-4.
35. Zhu X, Chen J, Scheideler L, Altebaeumer T, Geis-Gerstorfer J, 
Kern D. Cellular reactions of osteoblasts to micron-  and 
submicron-scale porous structures of titanium surfaces. Cells 
Tissues Organs 2004;178:13-22.
36. Rosen JJ, Culp LA. Morphology and cellular origins of 
substrate-attached material from mouse fi broblasts. Exp Cell 
Res 1977;107:139-49.
37. Albrecht-Buehler G. Filopodia of spreading 3T3 cells. Do they 
have a substrate-exploring function? J Cell Biol 1976;69:275-86.
38. Adams JC. Cell-matrix contact structures. Cell Mol Life Sci 
2001;58:371-92.
39. Joos U, Büchter A, Wiesmann HP, Meyer U. Strain driven fast 
osseointegration of implants. Head Face Med 2005;1:6.
40. Schwartz Z, Martin JY, Dean DD, Simpson J, Cochran DL, 
Boyan BD. Eff ect of titanium surface roughness on chondrocyte 
proliferation, matrix production, and diff erentiation depends on 
the state of cell maturation. J Biomed Mater Res 1996;30:145-55.
41. Rajpurohit R, Koch CJ, Tao Z, Teixeira CM, Shapiro IM. 
Adaptation of chondrocytes to low oxygen tension: Relationship 
between hypoxia and cellular metabolism. J  Cell Physiol 
1996;168:424-32.
42. Colnot C, Romero DM, Huang S, Rahman J, Currey JA, Nanci A, 
et al. Molecular analysis of healing at a bone-implant interface. 
J Dent Res 2007;86:862-7.
43. Depprich R, Zipprich H, Ommerborn M, Mahn E, Lammers L, 
Handschel J, et al. Osseointegration of zirconia implants: An 
SEM observation of the bone-implant interface. Head Face Med 
2008;4:25.
44. Büchter A, Joos U, Wiesmann HP, Seper L, Meyer U. Biological 
and biomechanical evaluation of interface reaction at conical 
screw-type implants. Head Face Med 2006;2:5.
45. Davies JE. Understanding peri-implant endosseous healing. 
J Dent Educ 2003;67:932-49.
46. Shalabi MM, Gortemaker A, Van’t Hof MA, Jansen JA, 
Creugers NH. Implant surface roughness and bone healing: A 
systematic review. J Dent Res 2006;85:496-500.
47. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG. Animal 
models for implant biomaterial research in bone: A review. Eur 
Cell Mater 2007;13:1-10.
48. Schneider GB, Perinpanayagam H, Clegg M, Zaharias R, 
Seabold D, Keller J, et al. Implant surface roughness aff ects 
osteoblast gene expression. J Dent Res 2003;82:372-6.
